 <h1>Ecoza Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>econazole topical</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about econazole topical. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ecoza.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to econazole topical: topical cream, topical foam</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, econazole topical (the active ingredient contained in Ecoza) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking econazole topical:</p><p>
<i>Less common</i>
</p><ul>
<li>Burning, itching, stinging, redness, or other sign of irritation at the application site</li>
<li>rash</li>
</ul><p>
<!-- end topical cream, topical foam --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to econazole topical: compounding powder, topical cream, topical foam</i></p><h3>Dermatologic</h3><p>Topical Cream:</p>
<p>-Common (1% to 10%): Pruritus/itching, skin burning sensation/burning, erythema</p>
<p>-Frequency not reported: Pruritic rash</p>
<p>-Postmarketing reports: Angioedema, contact dermatitis, rash, urticaria, blister, skin exfoliation</p>
<p></p>
<p>Vaginal Cream and Pessaries:</p>
<p>-Common (1% to 10%): Pruritus, skin burning sensation</p>
<p>-Uncommon (0.1% to 1%): Rash</p>
<p>-Rare (0.01% to 0.1%): Erythema</p>
<p>-Postmarketing reports: Angioedema, urticaria, contact dermatitis, skin exfoliation<sup>[Ref]</sup></p><h3>Other</h3><p>Topical Cream:</p>
<p>-Common (1% to 10%): Pain/stinging</p>
<p>-Uncommon (0.1% to 1%): Discomfort, swelling<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Vaginal Cream and Pessaries:</p>
<p>-Uncommon (0.1% to 1%): Vulvovaginal burning sensation<sup>[Ref]</sup></p><h3>Local</h3><p>One patient developed erythematous, edematous, urticarial-like lesions with vesiculation at the site of drug application.  Sensitivity to this drug was confirmed by patch testing.<sup>[Ref]</sup></p><p>Topical Cream:</p>
<p>-Frequency not reported: Lesions with vesiculation at site of application</p>
<p></p>
<p>Topical Foam:</p>
<p>-Uncommon (0.1% to 1%): Application site reactions</p>
<p></p>
<p>Vaginal Cream and Pessaries:</p>
<p>-Postmarketing reports: Application site pain, application site irritation, application site swelling<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Topical Cream:</p>
<p>-Frequency not reported: Drug sensitivity</p>
<p>-Postmarketing reports: Hypersensitivity</p>
<p></p>
<p>Vaginal Cream and Pessaries:</p>
<p>-Postmarketing reports: Hypersensitivity<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Spectazole (econazole)." Ortho Pharmaceutical Corporation, Raritan, NJ. </p><p id="ref_3">3. Millikan LE, Galen WK, Gewirtzman GB, Horwitz SN, Landow RK, Nesbitt LT Jr, Roth HL, Sefton J, Day RM "Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis." J Am Acad Dermatol 18 (1988): 52-6</p><p id="ref_4">4. Valsecchi R, Tornaghi A, Tribbia G, Cainelli T "Contact dermatitis from econazole." Contact Dermatitis 8 (1982): 422</p><p id="ref_5">5. Heel RC, Brogden RN, Speight TM, Avery GS "Econazole: a review of its antifungal activity and therapeutic efficacy." Drugs 16 (1978): 177-201</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Ecoza (econazole topical)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: topical antifungals</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Ecoza Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Spectazole</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Tinea Pedis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to econazole topical: compounding powder, topical cream, topical foam</i></p><h3>Dermatologic</h3><p>Topical Cream:</p><p>-Common (1% to 10%): Pruritus/itching, skin burning sensation/burning, erythema</p><p>-Frequency not reported: Pruritic rash</p><p>-Postmarketing reports: Angioedema, contact dermatitis, rash, urticaria, blister, skin exfoliation</p><p></p><p>Vaginal Cream and Pessaries:</p><p>-Common (1% to 10%): Pruritus, skin burning sensation</p><p>-Uncommon (0.1% to 1%): Rash</p><p>-Rare (0.01% to 0.1%): Erythema</p><p>-Postmarketing reports: Angioedema, urticaria, contact dermatitis, skin exfoliation<sup>[Ref]</sup></p><h3>Other</h3><p>Topical Cream:</p><p>-Common (1% to 10%): Pain/stinging</p><p>-Uncommon (0.1% to 1%): Discomfort, swelling<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Vaginal Cream and Pessaries:</p><p>-Uncommon (0.1% to 1%): Vulvovaginal burning sensation<sup>[Ref]</sup></p><h3>Local</h3><p>One patient developed erythematous, edematous, urticarial-like lesions with vesiculation at the site of drug application.  Sensitivity to this drug was confirmed by patch testing.<sup>[Ref]</sup></p><p>Topical Cream:</p><p>-Frequency not reported: Lesions with vesiculation at site of application</p><p></p><p>Topical Foam:</p><p>-Uncommon (0.1% to 1%): Application site reactions</p><p></p><p>Vaginal Cream and Pessaries:</p><p>-Postmarketing reports: Application site pain, application site irritation, application site swelling<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Topical Cream:</p><p>-Frequency not reported: Drug sensitivity</p><p>-Postmarketing reports: Hypersensitivity</p><p></p><p>Vaginal Cream and Pessaries:</p><p>-Postmarketing reports: Hypersensitivity<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Spectazole (econazole)." Ortho Pharmaceutical Corporation, Raritan, NJ. </p><p id="ref_3">3. Millikan LE, Galen WK, Gewirtzman GB, Horwitz SN, Landow RK, Nesbitt LT Jr, Roth HL, Sefton J, Day RM "Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis." J Am Acad Dermatol 18 (1988): 52-6</p><p id="ref_4">4. Valsecchi R, Tornaghi A, Tribbia G, Cainelli T "Contact dermatitis from econazole." Contact Dermatitis 8 (1982): 422</p><p id="ref_5">5. Heel RC, Brogden RN, Speight TM, Avery GS "Econazole: a review of its antifungal activity and therapeutic efficacy." Drugs 16 (1978): 177-201</p><h2>More about Ecoza (econazole topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: topical antifungals</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Ecoza Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Tinea Pedis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>